{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:20:01Z","timestamp":1793496001617,"version":"4.5.0"},"reference-count":87,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,7,19]]},"DOI":"10.1001\/jama.2022.11176","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:13:33Z","timestamp":1658229213000},"page":"280","source":"Crossref","is-referenced-by-count":329,"title":["Diagnosis and Management of Hyponatremia"],"prefix":"10.1001","volume":"328","author":[{"given":"Horacio J.","family":"Adrogu\u00e9","sequence":"first","affiliation":[{"name":"Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas"},{"name":"Division of Nephrology, Department of Medicine, Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"Tucker","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas"},{"name":"Division of Nephrology, Department of Medicine, Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaos E.","family":"Madias","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts"},{"name":"Division of Nephrology, Department of Medicine, St Elizabeth\u2019s Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"jrv220011r1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/issn.0301-3073","article-title":"Etiology and epidemiology of hyponatremia.","volume":"52","author":"Burst","year":"2019","journal-title":"Front Horm Res"},{"key":"jrv220011r2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/issn.0301-3073","article-title":"Hypervolemic hyponatremia in heart failure.","volume":"52","author":"Davila","year":"2019","journal-title":"Front Horm Res"},{"key":"jrv220011r3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/issn.0301-3073","article-title":"Hypervolemic hyponatremia (liver).","volume":"52","author":"Sol\u00e0","year":"2019","journal-title":"Front Horm Res"},{"issue":"7","key":"jrv220011r5","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1681\/ASN.2012020128","article-title":"The challenge of hyponatremia.","volume":"23","author":"Adrogu\u00e9","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"jrv220011r7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJMra1812053","article-title":"New neuroscience of homeostasis and drives for food, water, and salt.","volume":"380","author":"Lowell","year":"2019","journal-title":"N Engl J Med"},{"key":"jrv220011r8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/issn.0301-3073","article-title":"Physiology and pathophysiology of water homeostasis.","volume":"52","author":"Rondon-Berrios","year":"2019","journal-title":"Front Horm Res"},{"key":"jrv220011r9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/issn.0301-3073","article-title":"Hyponatremia-inducing drugs.","volume":"52","author":"Liamis","year":"2019","journal-title":"Front Horm Res"},{"issue":"10","key":"jrv220011r10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"issue":"9","key":"jrv220011r11","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1172\/JCI89812","article-title":"Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia.","volume":"127","author":"Ware","year":"2017","journal-title":"J Clin Invest"},{"issue":"12","key":"jrv220011r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046539","article-title":"Clinical characteristics and outcomes of hyponatraemia associated with oral water intake in adults: a systematic review.","volume":"11","author":"Rangan","year":"2021","journal-title":"BMJ Open"},{"key":"jrv220011r13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/issn.0301-3073","article-title":"Exercise-associated hyponatremia.","volume":"52","author":"Hew-Butler","year":"2019","journal-title":"Front Horm Res"},{"key":"jrv220011r14","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia.","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"jrv220011r15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1056\/NEJMct1206321","article-title":"Hyperosmolar therapy for raised intracranial pressure.","volume":"367","author":"Ropper","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv220011r16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/17446651.2020.1755259","article-title":"Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia.","volume":"15","author":"Decaux","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"jrv220011r17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/jgs.13325","article-title":"Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study.","volume":"63","author":"Nigro","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"jrv220011r18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.semnephrol.2009.03.002","article-title":"The treatment of hyponatremia.","volume":"29","author":"Sterns","year":"2009","journal-title":"Semin Nephrol"},{"key":"jrv220011r19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/issn.0301-3073","article-title":"Hyponatremia is linked to bone loss, osteoporosis, fragility and bone fractures.","volume":"52","author":"Barsony","year":"2019","journal-title":"Front Horm Res"},{"issue":"8","key":"jrv220011r20","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/jbmr.380","article-title":"Mild hyponatremia as a risk factor for fractures: the Rotterdam Study.","volume":"26","author":"Hoorn","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"3","key":"jrv220011r21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1359\/jbmr.090827","article-title":"Hyponatremia-induced osteoporosis.","volume":"25","author":"Verbalis","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"4","key":"jrv220011r22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/cen.2018.89.issue-4","article-title":"Hyponatremia, falls and bone fractures: a systematic review and meta-analysis.","volume":"89","author":"Corona","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"jrv220011r23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/issn.0301-3073","article-title":"Adverse consequences of overly-rapid correction of hyponatremia.","volume":"52","author":"Sterns","year":"2019","journal-title":"Front Horm Res"},{"issue":"5","key":"jrv220011r24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/ane.v140.5","article-title":"Incidence of osmotic demyelination syndrome in Sweden: a nationwide study.","volume":"140","author":"Aegisdottir","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"jrv220011r25","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/ndt\/gfm138","article-title":"Treatment of hyponatraemia by urea decreases risks of brain complications in rats: brain osmolyte contents analysis.","volume":"22","author":"Soupart","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"jrv220011r26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ki.2014.273","article-title":"Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.","volume":"87","author":"Gankam Kengne","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"jrv220011r27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1046\/j.1525-139X.2003.03015.x","article-title":"Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? a case report and literature review.","volume":"16","author":"Oo","year":"2003","journal-title":"Semin Dial"},{"issue":"5","key":"jrv220011r28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0002-9343(87)90649-8","article-title":"Clinical assessment of extracellular fluid volume in hyponatremia.","volume":"83","author":"Chung","year":"1987","journal-title":"Am J Med"},{"issue":"5","key":"jrv220011r29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1053\/j.ajkd.2014.06.001","article-title":"Diagnosis and treatment of hyponatremia.","volume":"64","author":"Adrogu\u00e9","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"jrv220011r31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ki.2015.4","article-title":"Current treatment practice and outcomes: report of the Hyponatremia Registry.","volume":"88","author":"Greenberg","year":"2015","journal-title":"Kidney Int"},{"issue":"21","key":"jrv220011r32","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia.","volume":"342","author":"Adrogu\u00e9","year":"2000","journal-title":"N Engl J Med"},{"key":"jrv220011r33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/issn.0301-3073","article-title":"Hypovolemic hyponatremia.","volume":"52","author":"Mohottige","year":"2019","journal-title":"Front Horm Res"},{"issue":"12","key":"jrv220011r34","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1093\/ndt\/gfu263","article-title":"Desmopressin acetate (DDAVP)\u2013associated hyponatremia and brain damage: a case series.","volume":"29","author":"Achinger","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"jrv220011r35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2215\/CJN.10440917","article-title":"Treatment of severe hyponatremia.","volume":"13","author":"Sterns","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"jrv220011r36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.wem.2019.11.003","article-title":"Wilderness Medical Society clinical practice guidelines for the management of exercise-associated hyponatremia: 2019 update.","volume":"31","author":"Bennett","year":"2020","journal-title":"Wilderness Environ Med"},{"issue":"1","key":"jrv220011r37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0885066617702590","article-title":"Incidence of adverse events during peripheral administration of sodium chloride 3%.","volume":"33","author":"Dillon","year":"2018","journal-title":"J Intensive Care Med"},{"issue":"1","key":"jrv220011r38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4037\/ccn2021400","article-title":"Safety of peripheral administration of 3% hypertonic saline in critically ill patients: a literature review.","volume":"41","author":"Alenazi","year":"2021","journal-title":"Crit Care Nurse"},{"issue":"3","key":"jrv220011r39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.ajkd.2014.09.021","article-title":"Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: a case series.","volume":"65","author":"Ayus","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"jrv220011r40","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2215\/CJN.13061117","article-title":"Risk factors and outcomes of rapid correction of severe hyponatremia.","volume":"13","author":"George","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"jrv220011r41","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.34067\/KID.0004402021","article-title":"Osmotic demyelination syndrome following correction of hyponatremia by =10 mEq\/L per day.","volume":"2","author":"Tandukar","year":"2021","journal-title":"Kidney360"},{"issue":"9","key":"jrv220011r42","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1210\/jc.2019-00044","article-title":"Continuous versus bolus infusion of hypertonic saline in the treatment of symptomatic hyponatremia caused by SIAD.","volume":"104","author":"Garrahy","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"jrv220011r43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamainternmed.2020.5519","article-title":"Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: the SALSA randomized clinical trial.","volume":"181","author":"Baek","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"5","key":"jrv220011r44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1530\/EJE-20-1207","article-title":"Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study.","volume":"184","author":"Chifu","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"jrv220011r45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1053\/j.ajkd.2012.11.032","article-title":"Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.","volume":"61","author":"Sood","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"jrv220011r46","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/ndt\/gfk090","article-title":"Therapeutic approach in patients with dysnatraemias.","volume":"21","author":"Liamis","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"jrv220011r47","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ncpneph0335","article-title":"Does the Adrogu\u00e9-Madias formula accurately predict serum sodium levels in patients with dysnatremias?","volume":"2","author":"Ring","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"jrv220011r48","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.07.020","article-title":"Hypertonic saline for hyponatremia: meeting goals and avoiding harm.","author":"Rondon-Berrios","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"jrv220011r49","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.2215\/CJN.00910207","article-title":"Hypertonic saline for hyponatremia: risk of inadvertent overcorrection.","volume":"2","author":"Mohmand","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"jrv220011r50","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.2215\/CJN.03300807","article-title":"The Adrogu\u00e9-Madias formula revisited.","volume":"2","author":"Berl","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"jrv220011r51","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/ckj\/sfw034","article-title":"The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients.","volume":"9","author":"Hanna","year":"2016","journal-title":"Clin Kidney J"},{"issue":"2","key":"jrv220011r52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.xkme.2019.02.002","article-title":"Use of desmopressin in hyponatremia: foe and friend.","volume":"1","author":"Achinger","year":"2019","journal-title":"Kidney Med"},{"issue":"2","key":"jrv220011r53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2215\/CJN.00950113","article-title":"Use of desmopressin acetate in severe hyponatremia in the intensive care unit.","volume":"9","author":"Rafat","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"21","key":"jrv220011r54","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.v7.21","article-title":"Treatment of severe symptomatic hyponatremia.","volume":"7","author":"Tandukar","year":"2019","journal-title":"Physiol Rep"},{"issue":"6","key":"jrv220011r55","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.amjms.2021.03.012","article-title":"Evaluation of desmopressin in critically ill patients with hyponatremia requiring 3% hypertonic saline.","volume":"361","author":"Tran","year":"2021","journal-title":"Am J Med Sci"},{"key":"jrv220011r56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcrc.2021.03.010","article-title":"Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: a retrospective, propensity score-based, single-center cohort study.","volume":"64","author":"Jingushi","year":"2021","journal-title":"J Crit Care"},{"issue":"3","key":"jrv220011r57","doi-asserted-by":"publisher","first-page":"317.e1","DOI":"10.1016\/j.amjmed.2017.09.048","article-title":"Outcomes in severe hyponatremia treated with and without desmopressin.","volume":"131","author":"MacMillan","year":"2018","journal-title":"Am J Med"},{"issue":"4","key":"jrv220011r58","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2215\/CJN.13381217","article-title":"Commentary on treatment of severe hyponatremia.","volume":"13","author":"Seliger","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"jrv220011r59","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/00005072-199605000-00011","article-title":"Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.","volume":"55","author":"Soupart","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"jrv220011r60","first-page":"383","article-title":"Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia.","volume":"51","author":"Soupart","year":"1999","journal-title":"Clin Nephrol"},{"issue":"12","key":"jrv220011r61","doi-asserted-by":"publisher","first-page":"1362.e15","DOI":"10.1016\/j.amjmed.2015.04.040","article-title":"Desmopressin to prevent rapid sodium correction in severe hyponatremia: a systematic review.","volume":"128","author":"MacMillan","year":"2015","journal-title":"Am J Med"},{"issue":"4","key":"jrv220011r62","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/j.ajkd.2009.12.024","article-title":"A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion.","volume":"55","author":"Berl","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"jrv220011r63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fmed.2017.00141","article-title":"Vasopressin receptor antagonists in hyponatremia: uses and misuses.","volume":"4","author":"Rondon-Berrios","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"jrv220011r64","doi-asserted-by":"publisher","first-page":"e4360","DOI":"10.1210\/clinem\/dgaa619","article-title":"Fluid restriction therapy for chronic SIAD; results of a prospective randomized controlled trial.","volume":"105","author":"Garrahy","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"jrv220011r65","doi-asserted-by":"publisher","first-page":"e1042","DOI":"10.1210\/clinem\/dgaa826","article-title":"Commentary: evidence-based medicine for SIAD.","volume":"106","author":"Verbalis","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"jrv220011r66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.ajkd.2019.11.012","article-title":"Efficacy of furosemide, oral sodium chloride, and fluid restriction for treatment of syndrome of inappropriate antidiuresis (SIAD): an open-label randomized controlled study (THE EFFUSE-FLUID trial).","volume":"76","author":"Krisanapan","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"jrv220011r67","doi-asserted-by":"publisher","first-page":"R184","DOI":"10.1186\/cc9292","article-title":"Treatment of euvolemic hyponatremia in the intensive care unit by urea.","volume":"14","author":"Decaux","year":"2010","journal-title":"Crit Care"},{"issue":"5","key":"jrv220011r68","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2215\/CJN.06990711","article-title":"Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.","volume":"7","author":"Soupart","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"jrv220011r69","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/jcm3031043","article-title":"Actual therapeutic indication of an old drug: urea for treatment of severely symptomatic and mild chronic hyponatremia related to SIADH.","volume":"3","author":"Decaux","year":"2014","journal-title":"J Clin Med"},{"issue":"11","key":"jrv220011r70","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2215\/CJN.04020318","article-title":"Urea for the treatment of hyponatremia.","volume":"13","author":"Rondon-Berrios","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"jrv220011r71","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/cen.2019.90.issue-4","article-title":"Urea treatment in fluid restriction-refractory hyponatraemia.","volume":"90","author":"Lockett","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"jrv220011r72","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/cen.2019.90.issue-6","article-title":"Urea in cancer patients with chronic SIAD-induced hyponatremia: old drug, new evidence.","volume":"90","author":"Nervo","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"jrv220011r73","doi-asserted-by":"publisher","first-page":"c168","DOI":"10.1159\/000338539","article-title":"Long-term treatment of hyponatremic patients with nephrogenic syndrome of inappropriate antidiuresis: personal experience and review of published case reports.","volume":"120","author":"Vandergheynst","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"jrv220011r74","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/ASN.2019090944","article-title":"A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis.","volume":"31","author":"Refardt","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"jrv220011r75","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1159\/000509082","article-title":"SGLT-2 inhibitors to treat hyponatremia associated with SIADH: a novel indication?","volume":"51","author":"Sarafidis","year":"2020","journal-title":"Am J Nephrol"},{"issue":"23","key":"jrv220011r76","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMra1403672","article-title":"Vasopressin antagonists.","volume":"372","author":"Berl","year":"2015","journal-title":"N Engl J Med"},{"key":"jrv220011r77","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2147\/DDDT","article-title":"Dose comparison of conivaptan (Vaprisol\u00ae) in patients with euvolemic or hypervolemic hyponatremia\u2014efficacy, safety, and pharmacokinetics.","volume":"10","author":"Palmer","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"jrv220011r78","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia.","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"jrv220011r79","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1530\/EJE-10-1078","article-title":"Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion.","volume":"164","author":"Verbalis","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"jrv220011r80","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00228-020-02848-6","article-title":"Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.","volume":"76","author":"Kim","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"jrv220011r81","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.ajkd.2018.02.355","article-title":"Tolvaptan for the syndrome of inappropriate secretion of antidiuretic hormone: is the dose too high?","volume":"71","author":"Sterns","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"jrv220011r82","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.xkme.2019.09.004","article-title":"Equivalent efficacy and decreased rate of overcorrection in patients with syndrome of inappropriate secretion of antidiuretic hormone given very low-dose tolvaptan.","volume":"2","author":"Hanna","year":"2019","journal-title":"Kidney Med"},{"issue":"10","key":"jrv220011r83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm5100086","article-title":"Vasopressin receptor antagonists for the correction of hyponatremia in chronic heart failure: an underutilized therapeutic option in current clinical practice?","volume":"5","author":"De Vecchis","year":"2016","journal-title":"J Clin Med"},{"key":"jrv220011r84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fmed.2017.00017","article-title":"Treatment of cirrhosis-associated hyponatremia with midodrine and octreotide.","volume":"4","author":"Patel","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"jrv220011r85","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41395-018-0119-3","article-title":"The impact of albumin use on resolution of hyponatremia in hospitalized patients with cirrhosis.","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"jrv220011r86","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/ajt.2017.17.issue-10","article-title":"Prevention of the osmotic demyelination syndrome after liver transplantation: a multidisciplinary perspective.","volume":"17","author":"Crismale","year":"2017","journal-title":"Am J Transplant"},{"issue":"11","key":"jrv220011r87","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/lt.25327","article-title":"Hyponatremia in cirrhosis: implications for liver transplantation.","volume":"24","author":"Leise","year":"2018","journal-title":"Liver Transpl"},{"key":"jrv220011r4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/B978-0-323-47794-9.00007-X","volume-title":"National Kidney Foundation\u2019s Primer on Kidney Diseases","author":"Verbalis","year":"2018","edition":"7th ed"},{"key":"jrv220011r6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/B978-0-12-381462-3.00044-6","volume-title":"Seldin and Giebisch\u2019s The Kidney: Physiology and Pathophysiology","author":"Sterns","year":"2013","edition":"5th ed"},{"key":"jrv220011r30","unstructured":"Mount? DB. Hyponatremia. Accessed March 7, 2022. https:\/\/accessmedicine.mhmedical.com\/content.aspx?bookid=2129&sectionid=252877938"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2794358\/jama_adrogu_2022_rv_220011_1657919726.49616.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:11:22Z","timestamp":1700835082000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2794358"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7,19]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.11176","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,19]]}}}